These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34575790)

  • 1. Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases.
    Kiebist J; Schmidtke KU; Schramm M; König R; Quint S; Kohlmann J; Zuhse R; Ullrich R; Hofrichter M; Scheibner K
    J Fungi (Basel); 2021 Sep; 7(9):. PubMed ID: 34575790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of cyclophosphamide metabolites by a peroxygenase from Marasmius rotula for toxicological studies on human cancer cells.
    Steinbrecht S; Kiebist J; König R; Thiessen M; Schmidtke KU; Kammerer S; Küpper JH; Scheibner K
    AMB Express; 2020 Jul; 10(1):128. PubMed ID: 32683510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolactone sulfoxides as new reactive metabolites acting as bis-electrophiles: implication in clopidogrel and prasugrel bioactivation.
    Dansette PM; Levent D; Hessani A; Bertho G; Mansuy D
    Chem Res Toxicol; 2013 May; 26(5):794-802. PubMed ID: 23527615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel.
    Hagihara K; Kazui M; Kurihara A; Yoshiike M; Honda K; Okazaki O; Farid NA; Ikeda T
    Drug Metab Dispos; 2009 Nov; 37(11):2145-52. PubMed ID: 19704027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-pot synthesis of human metabolites of SAR548304 by fungal peroxygenases.
    Kiebist J; Holla W; Heidrich J; Poraj-Kobielska M; Sandvoss M; Simonis R; Gröbe G; Atzrodt J; Hofrichter M; Scheibner K
    Bioorg Med Chem; 2015 Aug; 23(15):4324-4332. PubMed ID: 26142319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic basis of the antiplatelet action of prasugrel.
    Schrör K; Siller-Matula JM; Huber K
    Fundam Clin Pharmacol; 2012 Feb; 26(1):39-46. PubMed ID: 21895761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the activation of thienopyridines by cytochromes P450 using a pharmacodynamic assay in vitro.
    Abell LM; Liu EC
    J Pharmacol Exp Ther; 2011 Nov; 339(2):589-96. PubMed ID: 21828263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prasugrel, a new thienopyridine].
    Schrör K; Huber K
    Hamostaseologie; 2007 Dec; 27(5):351-5. PubMed ID: 18060245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.
    Farid NA; Kurihara A; Wrighton SA
    J Clin Pharmacol; 2010 Feb; 50(2):126-42. PubMed ID: 19948947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multistep Biooxidation of 5-(Hydroxymethyl)furfural to 2,5-Furandicarboxylic Acid with H
    Swoboda A; Zwölfer S; Duhović Z; Bürgler M; Ebner K; Glieder A; Kroutil W
    ChemSusChem; 2024 Jun; 17(11):e202400156. PubMed ID: 38568785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs.
    Hagihara K; Kazui M; Ikenaga H; Nanba T; Fusegawa K; Takahashi M; Kurihara A; Okazaki O; Farid NA; Ikeda T
    Xenobiotica; 2009 Mar; 39(3):218-26. PubMed ID: 19280520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and fate of a sulfenic acid intermediate in the metabolic activation of the antithrombotic prodrug prasugrel.
    Dansette PM; Thébault S; Bertho G; Mansuy D
    Chem Res Toxicol; 2010 Jul; 23(7):1268-74. PubMed ID: 20557086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Unspecific Peroxygenase from
    König R; Kiebist J; Kalmbach J; Herzog R; Schmidtke KU; Kellner H; Ullrich R; Jehmlich N; Hofrichter M; Scheibner K
    Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35888989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.
    Jakubowski JA; Winters KJ; Naganuma H; Wallentin L
    Cardiovasc Drug Rev; 2007; 25(4):357-74. PubMed ID: 18078435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two New Unspecific Peroxygenases from Heterologous Expression of Fungal Genes in Escherichia coli.
    Linde D; Olmedo A; González-Benjumea A; Estévez M; Renau-Mínguez C; Carro J; Fernández-Fueyo E; Gutiérrez A; Martínez AT
    Appl Environ Microbiol; 2020 Mar; 86(7):. PubMed ID: 31980430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine.
    Hagihara K; Nishiya Y; Kurihara A; Kazui M; Farid NA; Ikeda T
    Drug Metab Pharmacokinet; 2008; 23(6):412-20. PubMed ID: 19122335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on antiplatelet effect of a new thiophenopyridine platelets P2Y
    Xu Z; Gu J; Gao M; Du N; Liu P; Xu X; Wang J; Cao X
    Thromb Res; 2018 Oct; 170():192-199. PubMed ID: 30199785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer.
    Dansette PM; Rosi J; Bertho G; Mansuy D
    Chem Res Toxicol; 2012 Feb; 25(2):348-56. PubMed ID: 22103858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cangrelor inhibits the binding of the active metabolites of clopidogrel and prasugrel to P2Y12 receptors in vitro.
    Judge HM; Buckland RJ; Jakubowski JA; Storey RF
    Platelets; 2016; 27(3):191-5. PubMed ID: 26270719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability.
    Ancrenaz V; Daali Y; Fontana P; Besson M; Samer C; Dayer P; Desmeules J
    Curr Drug Metab; 2010 Oct; 11(8):667-77. PubMed ID: 20942779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.